Pyrolysis Mass Spectrometry A Predictor of Clinical Response to Treatment in Pulmonary Opportunist Mycobacterial Infection Preliminary Work with M. malmoense》.pdf

Pyrolysis Mass Spectrometry A Predictor of Clinical Response to Treatment in Pulmonary Opportunist Mycobacterial Infection Preliminary Work with M. malmoense》.pdf

  1. 1、本文档共8页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Pyrolysis Mass Spectrometry A Predictor of Clinical Response to Treatment in Pulmonary Opportunist Mycobacterial Infection Preliminary Work with M. malmoense》.pdf

Zbl. Bakt. 285, 291-298 (1996) © Gustav Fischer Verlag, Jena Pyrolysis Mass Spectrometry: A Predictor of Clinical Response to Treatment in Pulmonary Opportunist Mycobacterial Infection: Preliminary Work with M. malmoense M. L. HEGINBOTHOM and J. T. MAGEE Department of Medical Microbiology and Public Health Laboratory, University Hospital of Wales, Cardiff, UK Summary Pyrolysis mass spectrometry (Py-MS) yields data reflecting overall cell composition. The changes in composition induced by treatment with rifampicin and ethambutol, alone and in combination, were investigated for a collection of seven strains of Mycobacterium mal- moense from pulmonary infections. Two strains, both from patients that had responded to therapy with this combination, showed large changes in composition from control, un- treated cultures. The difference was particularly marked for the ethambutol treated cultures. Four strains, all from patients who had failed to respond to therapy with this combination, showed minimal changes in composition for all treatments. The remaining strain also show- ed minimal treatment-induced change, but, for this patient, therapy with the combination had proved successful. Minimum inhibitory concentrations (MICs) were determined radio- metrically. All strains showed MICs 0.5 !J.glmL for rifampicin (sensitive) and of 8 !J.glmL for ethambutol (resistant). MIC results did not correlate with clinical response, whereas the Py-MS results correlated with clinical response for six of the seven isolates. Py-MS may have a role in predicting effective therapy for this problem group. Introduction Opportunist mycobacteria are a recognised cause of pulmonary disease (5, 8, 29, 30, 33, 36, 37), the treatment of which requires a combination of antimycobacterial agents. The combination of agents combats the emergence of resistant mutants, and targets distinct portions of the heterogeneous bacterial popul

文档评论(0)

ycwf + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档